# Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment

> **NCT05724212** · — · ACTIVE_NOT_RECRUITING · sponsor: **Paola Mantegani** · enrollment: 220 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DIAGNOSTIC_TEST:** Interferon gamma release assay (IGRA)

## Key facts

- **NCT ID:** NCT05724212
- **Lead sponsor:** Paola Mantegani
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-27
- **Primary completion:** 2021-05-13
- **Final completion:** 2025-02-01
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05724212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05724212, "Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05724212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*